Aberdeen Group plc Has $230,000 Stake in DaVita Inc. $DVA

Key Points

• Aberdeen Group plc reduced its DaVita stake by 82.5% in Q4, selling 9,522 shares and finishing the period with 2,024 shares worth $230,000.
• DaVita beat quarterly estimates with $3.40 EPS vs. $3.24 expected and $3.62B revenue (up 9.9% YoY), and set FY2026 guidance of 13.60–15.00 EPS.
• Analysts' consensus is a "Hold" rating with an average price target of $155.80 (one Buy, five Holds, one Sell), and institutional investors own about 90.12% of the stock.

Aberdeen Group plc decreased its position in DaVita Inc. (NYSE:DVA - Free Report) by 82.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,024 shares of the company's stock after selling 9,522 shares during the quarter. Aberdeen Group plc's holdings in DaVita were worth $230,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. National Pension Service acquired a new stake in shares of DaVita in the third quarter valued at about $1,305,000. Todd Asset Management LLC acquired a new stake in shares of DaVita in the third quarter valued at about $21,842,000. Intech Investment Management LLC increased its position in shares of DaVita by 122.4% in the third quarter. Intech Investment Management LLC now owns 27,441 shares of the company's stock valued at $3,646,000 after acquiring an additional 15,104 shares during the last quarter. Doma Perpetual Capital Management LLC increased its position in shares of DaVita by 23.3% in the third quarter. Doma Perpetual Capital Management LLC now owns 355,574 shares of the company's stock valued at $47,245,000 after acquiring an additional 67,214 shares during the last quarter. Finally, Assenagon Asset Management S.A. increased its position in shares of DaVita by 1,951.8% in the third quarter. Assenagon Asset Management S.A. now owns 68,408 shares of the company's stock valued at $9,089,000 after acquiring an additional 65,074 shares during the last quarter. Institutional investors and hedge funds own 90.12% of the company's stock.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on DVA shares. UBS Group lifted their target price on DaVita from $186.00 to $190.00 and gave the company a "buy" rating in a research report on Wednesday, February 4th. Truist Financial set a $158.00 target price on DaVita in a research report on Thursday, February 5th. Weiss Ratings reaffirmed a "hold (c)" rating on shares of DaVita in a research report on Monday, December 29th. Wall Street Zen raised DaVita from a "hold" rating to a "buy" rating in a research report on Saturday, February 21st. Finally, Barclays boosted their price target on DaVita from $143.00 to $158.00 and gave the stock an "equal weight" rating in a research report on Tuesday, February 3rd. One research analyst has rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, DaVita has an average rating of "Hold" and an average price target of $155.80.

DaVita Trading Down 0.5%

Shares of DVA stock opened at $149.89 on Friday. The stock has a market cap of $10.01 billion, a P/E ratio of 15.13, a price-to-earnings-growth ratio of 0.53 and a beta of 0.92. The stock has a 50 day simple moving average of $148.90 and a 200 day simple moving average of $129.47. DaVita Inc. has a 1 year low of $101.00 and a 1 year high of $159.42.

DaVita (NYSE:DVA - Get Free Report) last issued its quarterly earnings results on Monday, February 2nd. The company reported $3.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.24 by $0.16. The business had revenue of $3.62 billion during the quarter, compared to analysts' expectations of $3.51 billion. DaVita had a negative return on equity of 413.18% and a net margin of 5.47%.The firm's revenue for the quarter was up 9.9% compared to the same quarter last year. During the same period in the previous year, the company posted $2.24 earnings per share. DaVita has set its FY 2026 guidance at 13.600-15.00 EPS. Analysts forecast that DaVita Inc. will post 10.76 EPS for the current year.

About DaVita

DaVita Inc NYSE: DVA is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.

Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DaVita Inc. (NYSE:DVA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.